MOTCO’s Regeneron Pharmaceuticals REGN Stock Holding History

MOTCO’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.28K	Hold	3	–	–	﹤0.01%	573
2026 Q2	$1.87K	Buy	3 +2	+200%	+$1.36K	﹤0.01%	539
2026 Q1	$773	Hold	1	–	–	﹤0.01%	568
2025 Q4	$772	Hold	1	–	–	﹤0.01%	597
2025 Q3	$562	Hold	1	–	–	﹤0.01%	621
2025 Q2	$545	Hold	1	–	–	﹤0.01%	589
2025 Q1	$634	Buy	+1	New	+$688	﹤0.01%	571
2024 Q1	–	Sell	-10	Closed	-$8.78K	–	763
2023 Q4	$8.78K	Hold	10	–	–	﹤0.01%	489
2023 Q3	$8.23K	Hold	10	–	–	﹤0.01%	521
2023 Q2	$7.18K	Buy	+10	New	+$7.71K	﹤0.01%	527
2021 Q1	–	Sell	-5	Closed	-$2K	–	761
2020 Q4	$2K	Hold	5	–	–	﹤0.01%	694
2020 Q3	$3K	Hold	5	–	–	﹤0.01%	560
2020 Q2	$3K	Hold	5	–	–	﹤0.01%	518
2020 Q1	$2K	Buy	+5	New	+$2.06K	﹤0.01%	557
2019 Q3	–	Sell	-16	Closed	-$5K	–	694
2019 Q2	$5K	Buy	+16	New	+$5.33K	﹤0.01%	720
2016 Q4	–	Sell	-19	Closed	-$8K	–	630
2016 Q3	$8K	Buy	+19	New	+$7.62K	﹤0.01%	498

Other funds holding REGN

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

MOTCO's REGN Position: Q3 2026 in Review

MOTCO held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2026 at 3 shares worth $2.28K. The position accounts for ﹤0.01% of the portfolio, ranked #573.

MOTCO first reported a position in REGN in Q3 2016 and has held it in 16 quarters since. The position peaked at $8.78K in Q4 2023. 895 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

MOTCO held 3 shares of Regeneron Pharmaceuticals worth $2.28K as of Q3 2026.
MOTCO left its Regeneron Pharmaceuticals share count unchanged in Q3 2026.
Regeneron Pharmaceuticals made up ﹤0.01% of MOTCO's portfolio in Q3 2026, its #573 holding.
MOTCO first reported a position in Regeneron Pharmaceuticals in Q3 2016 and has held it in 16 quarters since.
MOTCO's Regeneron Pharmaceuticals position peaked at $8.78K in Q4 2023.
895 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on MOTCO's 13F filing for Q3 2026, filed 9 Nov 2026.